Navigation Links
POET Receives Additional $76 Million in Federal Funding For Commercialization of Cellulosic Ethanol
Date:10/7/2008

POET today announced that it will receive $76.3 million from the U.S. Department of Energy (DOE) to commercialize cellulosic ethanol production technology.

Sioux Falls, S.D. (Vocus) October 7, 2008-- POET, the largest producer of ethanol in the world, today announced that it will receive $76.3 million from the U.S. Department of Energy (DOE) to commercialize cellulosic ethanol production technology. A renewable, home-grown energy alternative, cellulosic ethanol produced from plants materials such as corn cobs and switchgrass has the potential to cut life cycle greenhouse gas emissions by up to 86 percent relative to gasoline.

In February 2007, POET was selected by the DOE for a total award of up to $80 million in federal funding for the construction of a commercial cellulosic ethanol production facility. The first phase of the agreement was signed in October 2007 and provided POET with an initial $3.7 million for preliminary design, engineering and feedstock collection. The agreement announced today provides the remaining $76.3 million for final design, construction, start-up and continuous operation of Project LIBERTY.

"Our company is honored to work with DOE on a project of such importance to our country," said Jeff Broin, CEO of POET. "It is universally accepted that we can't continue to spend hundreds of billions of dollars annually on imported oil. With more than a billion tons of available biomass in the U.S. and continued increases in crop yields, we can sustainably produce enough ethanol to displace almost all of the gasoline consumed in this country.

"Grain based ethanol has been and will continue to be an important part of our country's energy supply," Broin continued. "By pairing the production of cellulosic ethanol with our existing infrastructure of corn-based ethanol, we will continue to improve corn ethanol and accelera
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2

Related biology technology :

1. Imaging Diagnostic Systems Receives its First Order for its CT Laser Mammography System for Israel
2. BioMS Medicals relapsing-remitting multiple sclerosis trial receives positive review from Data Safety Monitoring Board
3. deCODE Receives Nasdaq Deficiency Notice Relating to Market Value
4. Botaneco receives natural ingredient approval from ECOCERT(R) for Hydresia(TM) G2
5. Monogram Receives NASDAQ Notification
6. BioMS Medicals phase III U.S. multiple sclerosis trial receives positive safety review from Data Safety Monitoring Board
7. Childrens Hospital of Pittsburgh of UPMC Receives Prestigious Recognition for Patient Safety Efforts in National Survey
8. University of Southern California Receives Cancer Diagnosis System for Detecting Esophageal Dysplasia
9. Celsis Receives Frost & Sullivan 2008 Best Practices Award
10. Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures
11. Cylex(TM) Receives ISO 13485:2003 and 9001:2000 Quality Certifications
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
POET Receives Additional $76 Million in Federal Funding For Commercialization of Cellulosic Ethanol 
POET Receives Additional $76 Million in Federal Funding For Commercialization of Cellulosic Ethanol